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The global prevalence of diabetes is rapidly increasing. Studies support the necessity of screening and interventions for prediabetes,
which could result in serious complications and diabetes.This study aimed at developing an intelligence-based screeningmodel for
prediabetes. Data from the Korean National Health and Nutrition Examination Survey (KNHANES) were used, excluding subjects
with diabetes. The KNHANES 2010 data (𝑛 = 4685) were used for training and internal validation, while data from KNHANES
2011 (𝑛 = 4566) were used for external validation. We developed two models to screen for prediabetes using an artificial neural
network (ANN) and support vector machine (SVM) and performed a systematic evaluation of the models using internal and
external validation. We compared the performance of our models with that of a screening score model based on logistic regression
analysis for prediabetes that had been developed previously. The SVM model showed the areas under the curve of 0.731 in the
external datasets, which is higher than those of the ANN model (0.729) and the screening score model (0.712), respectively. The
prescreeningmethods developed in this study performed better than the screening scoremodel that had been developed previously
and may be more effective method for prediabetes screening.
1. Introduction
The prevalence of type 2 diabetes is dramatically increasing,
resulting in a global public health issue [1]. The prevalence
of diabetes was estimated at 285 million or 6.4% of adults
in the world in 2010 [2], and this prevalence is expected to
rise to 552 million by 2030 [3].The increasing rates of obesity
are expected to result in a faster increase in the prevalence
of type 2 diabetes in the future [4]. However, owing to
the absence of symptoms and/or disease-related knowledge,
diabetes often goes undetected, and approximately one-third
of people with diabetes are not aware of their status [5–
7]. Therefore, development of a simple accurate screening
method is needed. Historically, the majority of the clinical
screening methods consisted of surveys developed using
logistic regression analyses to predict diabetes [8–13].
Prediabetes was first recognized as an intermediate
diagnosis and indication of a relatively high risk for the
future development of diabetes by the Expert Committee on
Diagnosis and Classification of DiabetesMellitus in 1997 [14],
and it has been reported that approximately 5–10% of patients
with untreated prediabetes subsequently develop diabetes
[15, 16]. This is significant considering that prediabetes based
on impaired fasting glucose (IFG) was estimated to affect 4.9
million people, accounting for 17.4% of Korean adults in 2005
[6], with a further 35% of adults in the US with prediabetes
in 2008 [17]. The definition of prediabetes includes a fasting
plasma glucose (FPG) level in the range of 100–125mg/dL
(5.6–6.9mmol/L), impaired glucose tolerance (IGT) (oral
glucose tolerance test (OGTT) 2 h measurement in the range
of 140–199mg/dL (7.8–11.0mmol/L)), or HbA1c level in the
range of 5.7–6.4% (39–46mmol/mol). Similar to diabetes,
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Figure 1: Flow chart of excluding subjects for the KNHANES 2010.
the risk of microvascular complications is increased with
prediabetes [18], and the risk for cardiovascular disease and
total mortality is almost twice as high in individuals with
prediabetes [19, 20]. Early diagnosis and intervention for
prediabetes could prevent these complications, prevent delay,
or prevent the transition to diabetes [21] and be cost-effective
[22].
Machine learning is an area of artificial intelligence
research, which uses statistical methods for data classifica-
tion. Several machine learning techniques have been applied
in clinical settings to predict disease and have shown higher
accuracy for diagnosis than classical methods [23]. Support
vectormachines (SVM) and artificial neural networks (ANN)
have been widely used approaches in machine learning.They
are themost frequently used supervised learningmethods for
analyzing complex medical data [24].
In this study, we aimed to develop and validate models
to predict prediabetes using artificial neural network (ANN)
and support vector machine (SVM) methods, which could
be effective as simple and accurate screening tools. The
model performance was compared to that of the screening
score model that we modified for prediabetes based on the
screening score for diabetes by Lee et al. [8], with respect
to accuracy and area under the curve (AUC) of the receiver
operating characteristic (ROC).
2. Materials and Methods
2.1. Data Source and Subjects. Data from theKoreanNational
Health andNutrition Examination Survey (KNHANES) 2010
[25] and 2011 [26] were used to develop and validate,
respectively, the ANN and SVM models for prediabetes.
The KNHANES is a cross-sectional survey that includes
approximately 800 questions; it is conducted by the Division
of Chronic Disease Surveillance, Korea Centers for Disease
Control and Prevention. The survey represents the entire
nation using rolling sampling survey method. The following
exclusion criteria applied to the subjects in both datasets: <20
years of age, missing data for waist circumference, smoking
status, alcohol intake, bodymass index (BMI), physical activ-
ity, family history of diabetes, undetermined diabetic status or
hypertension status, and diagnosed diabetes or undiagnosed
diabetes. Diagnosed and undiagnosed patients were excluded
in order to focusing on predicting prediabetes. Undiagnosed
diabetes was defined as a FPG ≥ 126mg/dL without diagnosis
by clinician. Of the 8,958 subjects in the KNHANES 2010,
4,685were included as shown in Figure 1.Of the 8,518 subjects
in theKNHANES2011, 4,566 subjectswere includedusing the
same flow chart as Figure 1. The subjects of the KNHANES
2010 and 2011 data sets were not overlapped.
Figure 2 illustrates the study flow. The development
dataset from KNHANES 2010 was randomly divided into
training and internal validation sets using a 2 : 1 ratio. The
training set (𝑛 = 3, 134) was used to construct the ANN
and SVM models. The internal validation set (𝑛 = 1, 551)
was used to assess the ability to predict prediabetes. Addi-
tionally, data from KNHANES 2011 were used as an external
validation set (𝑛 = 4, 566). All individuals in the surveys
participated voluntarily and informed consent was obtained
from all participants. The survey protocol was approved by
the Institutional Review Board of the Korean Centers for
Disease Control and Prevention.
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Figure 2: Chart depicting the flow of data from the Korean National Health and Nutrition Examination Survey (KNHANES) 2010 and 2011
to develop and validate a prediabetes model. KNHANES: Korean National Health and Nutrition Examination Survey; ANN: artificial neural
network; SVM: support vector machine.
2.2. Risk Factors. We adopted the most frequently used nine
variables from previous studies regarding diabetes prediction
models: age, gender, family history of diabetes, hypertension,
alcohol intake, BMI, smoking status, waist circumference,
and physical activity [8–13]. FPG was determined using
glucose levels that were collected following ≥ 8 hours of
fasting. We considered only FPG although there are three
methods to diagnose prediabetes. In KNHANES 2010, FPG
was obtained from every subject, but OGTT was not tested,
and HbA1c was tested only for subjects with diabetes. A
family history of diabetes was limited to parents and siblings.
Hypertension was defined as systolic blood pressure (SBP)
> 140mmHg, diastolic blood pressure (DBP) > 90mmHg,
or use of medication for blood pressure control [8]. Alcohol
intake was calculated using 2 questions: (1) alcohol consump-
tion frequency during the previous 12months and (2) average
number of drinks on those days. The amount of alcohol
was calculated based on the number of glasses, regardless of
the kind of beverage, assuming that the amount of alcohol
was approximately the same in each glass (approximately
8 g alcohol per glass). Smoking status was divided into
“currently smoking regularly” and “others,” with the latter
group including subjects who had never smoked or had quit
smoking. The subjects who answered more than “moderate”
to the question “how intense is your everyday activity?” were
considered as physically active.
2.3. Artificial Neural Network. ANN is an artificial intelli-
gence technology, inspired by the architecture of biological
neurons such as that in the human brain [27].The technology
is specialized for classification, and it is mostly used to
identify underlying patterns for risk factors in medicine.
When trained properly, neural networks are known to have
more accurate predictive abilities than conventional methods
such as logistic regression. There have been a number of
recent advances in ANNmethodology that enable automatic
detection of an optimal predictive model [28, 29]. Unlike
logistic regression, ANNs are able to detect complex nonlin-
ear relationships between multiple predictors and diseases,
which make them useful in support systems for medical
decisions [30, 31].
The ANNmodels were constructed using NeuroSolution
version 6.0 (NeuroDimension, Gainesville, FL), which is
professional software that simplifies the construction of ANN
[32]. This software allows simultaneous testing of various
types of neural networks, including generalized regression
neural network, multilayer perceptron, probabilistic neural
network, radial basis neural network, feedforward neural
network, and support vector machine. To avoid overfitting,
the prediction models were internally validated using cross-
validation. Performance of the prediction models was moni-
tored during training and cross-validation to obtain optimal
algorithm and parameters, such as learning rate, momentum,
and number of hidden nodes. The ANN was trained with 7
predictors including age, gender, waist circumference, BMI,
family history of diabetes, hypertension, and alcohol intake,
which were selected using backward logistic regression. The
model chosen for prediabetes prediction was a multilayer
perceptron model with 1 hidden layer, batch training, and
momentum learning (MLP-1-BM) of backpropagation feed-
forward algorithm, which demonstrated the best perfor-
mance as a desired ANN.
2.4. Support Vector Machine. SVM maps data to a higher
dimensional space through a kernel function that linearly
separates data patterns. The data are divided into two groups
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Table 1: The weighted characteristics of the data from the Korean National Health and Nutrition Examination Survey (KNHANES) 2010.
Normal (𝑛 = 3,681) Prediabetes (𝑛 = 1,004) 𝑃∗
Age (years) 41.9 ± 0.5 [41.0–42.8] 52.5 ± 0.6 [51.3–53.7] <0.001
Gender (% men) 46.9 (0.9) [45.2–48.7] 58.8 (1.9) [55.0–62.5] <0.001
Family history of diabetes (%) 18.3 (0.9) [16.6–20.2] 22.9 (1.7) [19.8–26.4] 0.007
Current smoker (%) 27.5 (1.0) [25.5–29.6] 26.9 (1.9) [23.4–30.8] 0.799
Alcohol intake (drinks/day) 0.8 ± 0.0 [0.7–0.9] 1.0 ± 0.1 [0.9–1.2] <0.001
Physically active (%) 50.6 ± 1.1 [48.4–52.9] 52.1 ± 2.1 [48.0–56.3] 0.535
BMI (kg/m2) 23.2 ± 0.1 [23.1–23.3] 25.1 ± 0.1 [24.8–25.3] <0.001
Waist circumference (cm) 79.1 ± 0.2 [78.7–79.6] 85.8 ± 0.4 [85.1–86.6] <0.001
FPG (mg/dL) 89.0 ± 0.1 [88.7–89.3] 107.4 ± 0.3 [106.9–108.0] <0.001
Systolic blood pressure (mmHg) 116.8 ± 0.4 [116.0–117.5] 127.7 ± 0.7 [126.4–129.1] <0.001
Diastolic blood pressure (mmHg) 76.4 ± 0.3 [75.8–77.0] 81.5 ± 0.5 [80.6–82.4] <0.001
Hypertension (%) 16.4 (0.8) [14.9–18.0] 41.1 (2.2) [36.8–45.5] <0.001
BMI: body mass index; FPG: fasting plasma glucose.
Table values are given as mean ± standard error or % (standard error) [95% confidence interval] unless otherwise indicated. 𝑃∗ were obtained by 𝑡-test or chi-
square test.
Impaired fasting glucose was considered with values ≥ 100mg/dL and <126mg/dL.
by the training data referred to as a support vector. SVM
models are determined by choosing the maximum-margin
hyperplane with the nearest support vector of the two groups
[33]. SVM improves the accuracy of a model through the
optimization of separating space using the kernel function,
but one of the disadvantages of SVM is that it requires many
trials to construct an optimal SVMmodel in comparisonwith
other machine learning techniques [34].
The same seven risk factors as those in the ANN model
were employed for the SVM. To obtain the optimal model,
we adopted a grid search in which a range of parameter
values (penalty parameter [𝐶] of 0.01, 0.1, 1, 10, and 100
and scaling factor [𝜎] of 0.001, 0.01, 0.1, 1, 10, and 100) was
tested using the 10-fold cross-validation strategy.The optimal
parameter values with a𝐶 of 10 and 𝜎 of 10 for SVM using the
Gaussian kernel function were obtained. The SVM models
were constructed usingMATLAB Version 2012a (Mathworks
Inc., Natick, MA).
2.5. Screening Score of Our Models for Prediabetes. The
models constructed by ANN and SVM were compared
with a previously developed screening survey to illustrate
performance of our models and the possibility of their use
in real situations. For this purpose, we used a screening
score model for the Korean population constructed by Lee
et al. [8]; we felt this was appropriate because both studies
constructedmodels for the Korean population. Lee et al. used
data from KNHANES 2001 and 2005 for training and data
from KNHANES 2007 and 2008 for external validation. In
addition, the screening score model by Lee et al. used very
similar risk factors to ours, with the exception of current
smoking status. Those 6 variables independently associated
with undiagnosed diabetes were chosen for their model: age,
family history of diabetes, hypertension, waist circumference,
smoking, and alcohol intake.
The risk scorewas assigned according to the odds ratio for
each risk factor in the logistic regressionmodel defined by Lee
et al. [8]. Within the total score range of 0–11 points, a cut-
off score of ≥5 points was selected to indicate an individual
at high risk for undiagnosed diabetes; this cut-off resulted
in the highest value for the Youden index. The 6 risk factors
jointly yielded an AUC of 0.730 for both the internal and
external validation sets [8]. To compare with our models for
prediabetes, we constructed a new screening score model for
prediabetes by adjusting the cut-off point value based on our
definition of prediabetes (100mg/dL ≤ FPG < 126mg/dL),
given that the screening score for diabetes used by Lee et
al. was based on FPG ≥ 126mg/dL [8]. The screening score
for prediabetes was designed with the same risk score model
of the 6 risk factors using our training set for prediabetes
(KNHANES 2010) and the Youden index; as a result, a cut-
off score of ≥5 points was identified to indicate an individual
with prediabetes.
2.6. Statistical Analyses. The weighted characteristics of the
data from the KNHANES 2010 to represent the entire
normal and prediabetes people in Korea are summarized
by descriptive statistics in Table 1. For comparison of the
factors between normal and prediabetes, the continuous and
categorical characteristics were tested using 𝑡-test and chi-
square test, respectively.
To obtain the optimal variables for the prediction model,
backward logistic regression was performedwith the training
set. Each step of the backward regression excluded the
variables without a statistically meaningful correlation with
the outcome, prediabetes.Three steps of backward regression
were executed, and the selected 7 variables were age, BMI,
hypertension, gender, alcohol intake, waist circumference,
and family history. The Hosmer-Lemeshow test resulted in
a 𝑃 value of 0.132, indicating that the chosen variables were
well fitted.
ROC curve analysis is the most commonly used method
in clinical analysis to establish an optimal cut-off point [35].
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Table 2: Performance of the ANN, SVM, and screening score (Lee et al. [8]) models using the internal and external validation sets for
predicting prediabetes.
AUC Accuracy (%) Sensitivity (%) Specificity (%)
Internal validation set (𝑛 = 1,551)
ANN∗ 0.768 69.0 74.1 67.5
SVM† 0.761 64.9 78.9 61.2
Screening score‡ 0.734 63.4 76.1 60.0
External validation set (𝑛 = 4,566)
ANN∗ 0.729 60.7 77.2 56.7
SVM† 0.731 66.1 69.4 65.3
Screening score‡ 0.712 59.9 74.3 56.4
AUC: area under the curve; ANN: artificial neural network; SVM: support vector machine.
The internal validation set was comprised of data from the Korean National Health and Nutrition Examination Survey (KNHANES) 2010, and the external
validation set included data from KNHANES 2011. ∗The chosen model was a multilayer perceptron model with 1 hidden layer, batch training, and momentum
learning (MLP-1-B-M) of backpropagation feedforward algorithm. †The optimal model was found using Gaussian kernel function with a penalty parameter
(C) of 10 and scaling factor (𝜎) of 10. ‡The performance was calculated by applying the screening score model for prediabetes based on that of Lee et al. [8] to
the data from KNHANES 2010 and 2011.
Table 3: Performance of the screening score model (Lee et al. [8]) in predicting prediabetes and undiagnosed diabetes using the data from
the Korean National Health and Nutrition Examination Survey (KNHANES) 2010 and 2011.
AUC Accuracy (%) Sensitivity (%) Specificity (%)
Prediabetes KNHANES 2010
∗(internal validation) 0.734 63.4 76.1 60.0
KNHANES 2011∗(external validation) 0.712 59.9 74.3 56.4
Undiagnosed diabetes KNHANES 2010
†(internal validation) 0.772 66.6 76.5 66.4
KNHANES 2011†(external validation) 0.751 64.6 74.4 64.3
AUC: area under the curve; KNHANES: Korean National Health and Nutrition Examination Survey.
Prediabetes was defined as fasting plasma glucose, with values ≥100mg/dL and <126mg/dL. ∗Internal and external validation sets to evaluate the screening
score for prediabetes (𝑛 = 1,551 for KNHANES 2010 and 𝑛 = 4,566 for KNHANES 2011). †Internal and external validation sets to evaluate the screening score
for undiagnosed diabetes (𝑛 = 1,585 for KNHANES 2010 and 𝑛 = 4,683 for KNHANES 2011).
Therefore, we generated ROC curves and the selected cut-
off points that maximized the Youden index [36] to compare
the performance of our optimal machine learning models
with that of the screening score model for prediabetes based
on the screening score by Lee et al. [8], using our internal
and external validation sets. Following the ROC analysis, the
AUC, accuracy, sensitivity, and specificity of our models and
screening score model for prediabetes were calculated. The
classification accuracy measured the proportion of cases cor-
rectly classified. Sensitivity measured the fraction of positive
cases that were classified as positive. Specificity measured the
fraction of negative cases that were classified as negative. We
used SPSS 20.0 (IBM Corp, Armonk, NY) for statistical anal-
ysis and MedCalc 12.4 (MedCalc Inc., Mariakerke, Belgium)
for ROC analysis. Statistical significance was set at 𝑃 < 0.05.
3. Results
The weighted characteristics of the KNHANES 2010 data are
summarized in Table 1. The factors that were significantly
related to prediabetes were age, gender, family history of
diabetes, alcohol intake, BMI, waist circumference, FPG,
systolic and diastolic blood pressures, and hypertension.
When the prediction performance of the ANN model
using 10-fold cross-validation was assessed for the training
set, the final model showed an AUC of 0.706 and an accuracy
of 65.6% for prediabetes. Cross-validation of the optimal
SVM parameters with the training set resulted in an AUC of
0.742 and accuracy of 69.9%. These results are not included
in Table 2. The similar performance observed between the
training and validation sets in Table 2 indicates that the
trained models were not overfitting.
With both the internal and the external validation sets,
our ANN and SVMmodels showed better performance than
the existing screening score model using logistic regression,
especially in terms of AUC, which is known as a better
measure than accuracy in evaluating learning algorithms [37]
(Table 2). In the external validation set, the accuracy of the
SVMmodel was 5.4% and 6.2% higher than that of the ANN
and screening score models, respectively. The ROC curves of
the ANN, SVM, and screening score models are depicted for
the internal and external validation sets in Figure 3.
Table 3 shows the performance obtained by applying the
screening score model by Lee et al. [8] to the data from
KNHANES 2010 and 2011 for predicting prediabetes and
undiagnosed diabetes. For all performance parameters (AUC,
accuracy, sensitivity, and specificity) in both datasets, the
ability to predict prediabetes was inferior to that for diabetes.
In particular, the AUC and accuracy for prediabetes in the
external validation set were lower than those for undiagnosed
diabetes by 0.039 and4.7%, respectively. AUCand accuracy of
the SVMmodel for external validation are higher than those
of the screen score model for prediabetes by 0.019 and 6.2%,
respectively.
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Figure 3: Receiver operating characteristic curves (ROC) of artificial neural network (ANN), support vector machine (SVM), and screening
score in predicting prediabetes for internal validation set (a) and external validation set (b).
4. Discussion
The results of the present study indicate that the ANN
and SVM models that we developed to predict prediabetes,
defined as IFG, performed better than the existing clinical
screening scoremodel, as indicated by the AUC and accuracy
measures (Table 2). Although logistic regression analysis and
ANN share common roots in statistical pattern recognition,
the latter is a generalization of the former [38], which might
explain why our ANN model performed better than the
screening scoremodel, whichwas based on logistic regression
analysis. The SVM model performed particularly well due
to the ability of SVM to efficiently find a unique optimal
solution, incorporate multiple types of data with a degree
of flexibility, and model nonlinear patterns [39]. We also
investigated SVM models with different numbers of risk
factors to find optimal parameters. The best performance of
SVM model with six risk factors including age, body mass
index, hypertension, gender, daily alcohol intake, and waist
circumference was an AUC of 0.743 and accuracy of 70.2% in
training set, which was almost the same as the performance
of SVMmodel with seven risk factors in our paper, resulting
in an AUC of 0.742 and accuracy of 69.9%.
Meng et al. [40] compared the performance of logistic
regression, ANNs, and decision tree models for predicting
diabetes or prediabetes using common risk factors in China
population. In Meng et al. study, the ANNs model was the
poorest of the threemodels, with 73.23% accuracy.This result
is consistent with ours that the performance of ANN model
was lower than SVM model. However, the performance of
ANN can be case-by-case depending on characteristics of
data or developers.
Although similar statistical analyses were conducted (i.e.,
backward regression models), there were slight differences
in the variables included in the present study and those
in the study by Lee et al. [8]. Lee et al. included current
smoking status as a risk factor in the training set based on
the data from KNHANES 2001 and 2005; however, current
smoking status was not included in our training set using
data from KNHANES 2010. This may have resulted from
lifestyle changes in the Korean population between those
years, including a decline in the overall smoking rate and
stronger antismoking laws [41]. Although several screening
score models have been developed and used clinically, our
prediction model is unique in several ways.
First, owing to the similarity between our machine learn-
ing models and the existing screening score models, we were
able to compare the performance of our machine learning
models with the existing models. Second, to the best of our
knowledge, there are few studies investigating prediabetes;
instead, themajority of the othermodels have been developed
to predict undiagnosed diabetes. However, prediabetes is
increasingly becoming a significant public health issue. Using
our model to screen patients for prediabetes would enable
interventions at an earlier stage, which would be easier to
implement and more successful than interventions imple-
mented following diabetes screening.
Prediabetes was more difficult to predict than diabetes
using any of the parameters across all of the models, which
is not unexpected. AUC and accuracy of the SVM model
for external validation are higher than those of the screen
score model for prediabetes by 0.019 and 6.2%, respectively
(Table 2). Therefore, we demonstrated that the machine
learning methods could help to overcome the difficulty in
predicting prediabetes.
This study has certain limitations. First, FPG level was the
onlymeasurement that we used to define prediabetes and dia-
betes; OGTT and HbA1c were not taken into consideration.
Data were lacking for these measurements; however, the use
of FPG level was consistent with the model developed by Lee
et al. [8], with which we compared our models.
Second, the screening scoremodel for diabetes developed
by Lee et al. [8] did not correspond perfectly with our model
for prediabetes. For a more precise comparison in future
studies, a screening score model for prediabetes should be
constructed using the new regression equation with different
Computational and Mathematical Methods in Medicine 7
risk factors for prediabetes. In spite of this limitation, the
suggested model with the new cut-off point is considered
a good model for predicting prediabetes with AUCs of
0.734 and 0.712 in the internal and external validation sets,
respectively.
Last, the new models that we developed are limited in
terms of convenience and potential widespread use. Although
the screening score model is not the most effective one
for disease prediction, it is simple and accessible. However,
machine learning models could also become more accessible
through the use of calculator software, particularly with the
widespread use of devices such as computers, smart phones,
and tablet PCs. Future studies could develop a calculator in
which the values are entered via a website or application and
the results are immediately delivered to the end user. The
decision tree method is also warranted for easy interpreting
tree-like plot in the future.
5. Conclusion
Our study constructed a reasonably good model to predict
prediabetes in the Korean population. By applying simi-
lar methods in other countries, researchers could develop
country-specific machine learning models for nationwide
use.The creation of a user-friendly calculator programwould
enable access to screening by the general population, in
addition to medical professionals. This widespread use could
result in early diagnosis and treatment for people with
prediabetes and diabetes, helping to relieve the public health
diabetes burden and reducing the number of people who
remain undiagnosed.
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